Low Brain Intracellular Free Magnesium in Mitochondrial Cytopathies

The authors studied, by in vivo phosphorus magnetic resonance spectroscopy (31P-MRS), the occipital lobes of 19 patients with mitochondrial cytopathies to clarify the functional relation between energy metabolism and concentration of cytosolic free magnesium. All patients displayed defective mitochondrial respiration with low phosphocreatine concentration [PCr] and high inorganic phosphate concentration [Pi] and [ADP]. Cytosolic free [Mg2+] and the readily available free energy (defined as the actual free energy released by the exoergonic reaction of ATP hydrolysis, i.e., ΔGATPhyd) were abnormally low in all patients. Nine patients were treated with coenzyme Q10 (CoQ), which improved the efficiency of the respiratory chain, as shown by an increased [PCr], decreased [Pi] and [ADP], and increased availability of free energy (more negative value of ΔGATPhyd). Treatment with CoQ also increased cytosolic free [Mg2+] in all treated patients. The authors findings demonstrate low brain free [Mg2+] in our patients and indicate that it resulted from failure of the respiratory chain. Free Mg2+ contributes to the absolute value of ΔGATPhyd. The results also are consistent with the view that cytosolic [Mg2+] is regulated in the intact brain cell to equilibrate, at least in part, any changes in rapidly available free energy.

[1]  R. Moreno-Sánchez,et al.  Modulation of Oxidative Phosphorylation by Mg2+ in Rat Heart Mitochondria* , 1998, The Journal of Biological Chemistry.

[2]  P. Zaniol,et al.  Deficit of Brain and Skeletal Muscle Bioenergetics and Low Brain Magnesium in Juvenile Migraine: An in Vivo 31P Magnetic Resonance Spectroscopy Interictal Study , 1997, Pediatric Research.

[3]  P. Zaniol,et al.  Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study , 1997, Journal of the Neurological Sciences.

[4]  P. Zaniol,et al.  Phosphorus Magnetic Resonance Spectroscopy in Cluster Headache , 1997, Neurology.

[5]  G. Formiggini,et al.  Coenzyme Q deficiency in mitochondria: kinetic saturation versus physical saturation. , 1997, Molecular aspects of medicine.

[6]  S. Evers,et al.  Magnesium in the Prophylaxis of Migraine—a Double-Blind, Placebo-Controlled Study , 1996, Cephalalgia : an international journal of headache.

[7]  C. Wilimzig,et al.  Prophylaxis of Migraine with Oral Magnesium: Results From A Prospective, Multi-Center, Placebo-Controlled and Double-Blind Randomized Study , 1996, Cephalalgia : an international journal of headache.

[8]  R. Cracco,et al.  Intravenous Magnesium Sulfate Rapidly Alleviates Headaches of Various Types , 1996, Headache.

[9]  B. Barbiroli,et al.  In Vivo Assessment of Free Magnesium Concentration in Human Brain by 31P MRS. A New Calibration Curve Based on a Mathematical Algorithm , 1996, NMR in biomedicine.

[10]  N. Ramadan,et al.  Mitochondria, magnesium and migraine , 1995, Journal of the Neurological Sciences.

[11]  Z. Stelmasiak,et al.  Magnesium concentration in plasma and erythrocytes in MS , 1995, Acta neurologica Scandinavica.

[12]  P. Zaniol,et al.  Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation , 1995, Neurology.

[13]  S F Keevil,et al.  Quality assessment in in vivo NMR spectroscopy: II. A protocol for quality assessment. EEC Concerted Research Project. , 1995, Magnetic resonance imaging.

[14]  P. Zaniol,et al.  31P‐Magnetic resonance spectroscopy in migraine without aura , 1994, Neurology.

[15]  P. Zaniol,et al.  Defective Brain Energy Metabolism Shown by in vivo 31P MR Spectroscopy in 28 Patients with Mitochondrial Cytopathies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  K. Ota,et al.  Experimental and clinical studies on dysregulation of magnesium metabolism and the aetiopathogenesis of multiple sclerosis. , 1992, Magnesium research.

[17]  P. Zaniol,et al.  Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura , 1992, Neurology.

[18]  G Serratrice,et al.  31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies , 1992, Neurology.

[19]  K. Adachi,et al.  Magnesium and calcium contents in CNS tissues of amyotrophic lateral sclerosis patients from the Kii peninsula, Japan. , 1992, European neurology.

[20]  T. Brown,et al.  Free magnesium levels in normal human brain and brain tumors: 31P chemical-shift imaging measurements at 1.5 T. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Dobson,et al.  The Gibbs-Donnan near-equilibrium system of heart. , 1990, The Journal of biological chemistry.

[22]  R. Bryan,et al.  Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine , 1990, Annals of neurology.

[23]  K. Welch,et al.  Low Brain Magnesium in Migraine , 1989, Headache.

[24]  S. Levine,et al.  Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy , 1989, Neurology.

[25]  C. Hardy,et al.  Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance. , 1989, Clinical chemistry.

[26]  S Nioka,et al.  Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H A Krebs,et al.  Cytosolic phosphorylation potential. , 1979, The Journal of biological chemistry.